2026. Prospective, Single-Center, Phase II Study to Standardize the Mitotane Dosing Regimen in Combination with Platinum-Based Chemotherapy in the First-Line Treatment for Adrenocortical Cancer. Voprosy onkologii. 72, 1 (Mar. 2026), OF-2404. DOI:https://doi.org/10.37469/0507-3758-2026-72-1-OF-2404.